taurine has been researched along with Hyperlipemia in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of taurine supplementation on the serum cholesterol levels and the progression of atherosclerosis were investigated in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail." | 7.76 | Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation. ( Fukuda, N; Murakami, S; Nasu, T; Sakono, M; Sakurai, T; Tomoike, H, 2010) |
| "The effects of taurine on insulin sensitivity were examined in a model rat of insulin resistance and type 2 diabetes-the Otsuka Long-Evans Tokushima Fatty (OLETF) rat." | 7.70 | Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. ( Harada, N; Minami, A; Nakaya, Y; Niwa, Y; Ohnaka, M; Sakamoto, S, 2000) |
| "Taurine was used in the present study to evaluate its beneficial effects against proteinuria and hyperlipidemia associated with nephrotic syndrome." | 7.69 | Protection by taurine against adriamycin-induced proteinuria and hyperlipidemia in rats. ( Arumugam, V; Karthikeyan, J; Venkatesan, N; Venkatesan, P, 1997) |
| "Atherosclerosis is the underlying mechanism of cardiovascular disease including myocardial infarctions, strokes and peripheral artery disease and remains a major cause of morbidity and mortality worldwide." | 6.50 | Taurine and atherosclerosis. ( Murakami, S, 2014) |
| "The effects of taurine supplementation on the serum cholesterol levels and the progression of atherosclerosis were investigated in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail." | 3.76 | Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation. ( Fukuda, N; Murakami, S; Nasu, T; Sakono, M; Sakurai, T; Tomoike, H, 2010) |
| "We sought to determine whether taurine could specifically protect against coronary artery disease during an atherogenic diet and whether taurine affects the lipid profile, metabolites of methionine, and endothelial atherogenic systems." | 3.75 | High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. ( Carru, C; Hare, DL; Jin, X; Lau, E; Learmont, J; Schwartz, GD; Sutarga, K; Wijaya, BP; Wookey, PJ; Zinellu, A; Zulli, A, 2009) |
| "The effects of taurine on insulin sensitivity were examined in a model rat of insulin resistance and type 2 diabetes-the Otsuka Long-Evans Tokushima Fatty (OLETF) rat." | 3.70 | Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. ( Harada, N; Minami, A; Nakaya, Y; Niwa, Y; Ohnaka, M; Sakamoto, S, 2000) |
| "Taurine was used in the present study to evaluate its beneficial effects against proteinuria and hyperlipidemia associated with nephrotic syndrome." | 3.69 | Protection by taurine against adriamycin-induced proteinuria and hyperlipidemia in rats. ( Arumugam, V; Karthikeyan, J; Venkatesan, N; Venkatesan, P, 1997) |
| "Hyperlipidemia, an independent risk factor for atherosclerosis, is regarded as a lipid metabolism disorder associated with elevated plasma triglyceride and/or cholesterol." | 2.72 | The molecular targets of taurine confer anti-hyperlipidemic effects. ( Dong, Y; Gao, J; Li, X; Liu, Y; Tao, J, 2021) |
| "Atherosclerosis is the underlying mechanism of cardiovascular disease including myocardial infarctions, strokes and peripheral artery disease and remains a major cause of morbidity and mortality worldwide." | 2.50 | Taurine and atherosclerosis. ( Murakami, S, 2014) |
| "The results showed that hyperlipemia induced dyslipidemia in rats, which was alleviated by ginsenoside Rb_1." | 1.91 | [Discovery of biomarkers related to abnormal lipid metabolism in liver and serum and intervention mechanism of ginsenoside Rb_1 in hyperlipidemia rats based on non-targeted metabolomics]. ( Leng, X; Ma, YX, 2023) |
| "The effectiveness of MG on hyperlipidemia is proved using the established metabolomic method and the regulated metabolic pathways involve the TCA cycle, taurine and hypotaurine metabolism, glyoxylate and dicarboxylate metabolism, glycine and serine and threonine metabolism, glycerophospholipid metabolism, primary bile acid biosynthesis etc." | 1.42 | A high-throughput metabolomic approach to explore the regulatory effect of mangiferin on metabolic network disturbances of hyperlipidemia rats. ( Du, S; Gong, L; Huang, Y; Li, G; Li, Y; Shi, Z; Sun, C; Wang, M; Yin, J; Zhou, C, 2015) |
| "Treatment with taurine (470 mg/kg/day, p." | 1.27 | Effects of taurine on neutrophil function in hyperlipidemic rats. ( Horisaka, K; Koeda, T; Masuda, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Leng, X | 1 |
| Ma, YX | 1 |
| Dong, Y | 1 |
| Li, X | 1 |
| Liu, Y | 1 |
| Gao, J | 1 |
| Tao, J | 1 |
| Huang, S | 1 |
| Wu, Q | 1 |
| Liu, H | 1 |
| Ling, H | 1 |
| He, Y | 1 |
| Wang, C | 1 |
| Wang, Z | 1 |
| Lu, Y | 2 |
| Zhou, C | 1 |
| Li, G | 1 |
| Li, Y | 2 |
| Gong, L | 1 |
| Huang, Y | 1 |
| Shi, Z | 1 |
| Du, S | 1 |
| Wang, M | 1 |
| Yin, J | 1 |
| Sun, C | 1 |
| Murakami, S | 4 |
| Sakurai, T | 3 |
| Tomoike, H | 1 |
| Sakono, M | 1 |
| Nasu, T | 1 |
| Fukuda, N | 1 |
| Zulli, A | 1 |
| Lau, E | 1 |
| Wijaya, BP | 1 |
| Jin, X | 1 |
| Sutarga, K | 1 |
| Schwartz, GD | 1 |
| Learmont, J | 1 |
| Wookey, PJ | 1 |
| Zinellu, A | 1 |
| Carru, C | 1 |
| Hare, DL | 1 |
| Gaamoussi, F | 1 |
| Israili, ZH | 1 |
| Lyoussi, B | 1 |
| Mikami, N | 1 |
| Hosokawa, M | 1 |
| Miyashita, K | 1 |
| Matsushima, Y | 1 |
| Sekine, T | 1 |
| Kondo, Y | 2 |
| Kameo, K | 1 |
| Tachibana, M | 1 |
| Kinscherf, R | 1 |
| Cafaltzis, K | 1 |
| Röder, F | 1 |
| Hildebrandt, W | 1 |
| Edler, L | 1 |
| Deigner, HP | 1 |
| Breitkreutz, R | 1 |
| Feussner, G | 1 |
| Kreuzer, J | 1 |
| Werle, E | 1 |
| Michel, G | 1 |
| Metz, J | 1 |
| Dröge, W | 1 |
| Yamada, J | 1 |
| Masuda, M | 2 |
| Tanaka, M | 1 |
| Horisaka, K | 2 |
| Venkatesan, N | 1 |
| Venkatesan, P | 1 |
| Karthikeyan, J | 1 |
| Arumugam, V | 1 |
| Nakaya, Y | 1 |
| Minami, A | 1 |
| Harada, N | 1 |
| Sakamoto, S | 1 |
| Niwa, Y | 1 |
| Ohnaka, M | 1 |
| Takenaga, T | 1 |
| Imada, K | 1 |
| Otomo, S | 1 |
| Li, W | 1 |
| Tian, Y | 1 |
| Feng, H | 1 |
| Tu, B | 1 |
| Kitajima, H | 1 |
| Nagate, T | 1 |
| Danielsson, H | 1 |
| Sjövall, J | 2 |
| Koeda, T | 1 |
| Szantay, I | 1 |
| Popescu, TA | 1 |
| Cucuianu, M | 1 |
| Lindstedt, S | 1 |
| Avigan, J | 1 |
| Goodman, DS | 1 |
| Steinberg, D | 1 |
3 reviews available for taurine and Hyperlipemia
| Article | Year |
|---|---|
The molecular targets of taurine confer anti-hyperlipidemic effects.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Autophagy; Cholesterol; Cholesterol 7-alpha-Hydroxy | 2021 |
Taurine and atherosclerosis.
Topics: Animals; Atherosclerosis; Disease Models, Animal; Humans; Hyperlipidemias; Myocardial Infarction; Ta | 2014 |
Bile acid metabolism.
Topics: Animals; Bile Acids and Salts; Cholelithiasis; Cholestasis; Cholesterol; Diet; Glycine; Hormones; Hy | 1975 |
18 other studies available for taurine and Hyperlipemia
| Article | Year |
|---|---|
[Discovery of biomarkers related to abnormal lipid metabolism in liver and serum and intervention mechanism of ginsenoside Rb_1 in hyperlipidemia rats based on non-targeted metabolomics].
Topics: Animals; Biomarkers; Ginsenosides; Hyperlipidemias; Lipid Metabolism; Liver; Metabolome; Metabolomic | 2023 |
Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids.
Topics: Alkaloids; Animals; Bile Acids and Salts; Cholesterol; Dendrobium; Diet, High-Fat; Homeostasis; Hype | 2019 |
A high-throughput metabolomic approach to explore the regulatory effect of mangiferin on metabolic network disturbances of hyperlipidemia rats.
Topics: Animals; Biomarkers; Cholesterol; Chromatography, Liquid; Discriminant Analysis; High-Throughput Scr | 2015 |
Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation.
Topics: Animals; Atherosclerosis; Cholesterol; Disease Models, Animal; Humans; Hypercholesterolemia; Hyperli | 2010 |
High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia.
Topics: Analysis of Variance; Animals; Apoptosis; CCAAT-Binding Factor; Coronary Artery Disease; Diet, Ather | 2009 |
Hypoglycemic and hypolipidemic effects of an aqueous extract of Chamaerops humilis leaves in obese, hyperglycemic and hyperlipidemic Meriones shawi rats.
Topics: Animals; Arecaceae; Blood Glucose; Body Weight; Diabetes Complications; Diabetes Mellitus, Experimen | 2010 |
Dietary combination of fish oil and taurine decreases fat accumulation and ameliorates blood glucose levels in type 2 diabetic/obese KK-A(y) mice.
Topics: Acyl-CoA Oxidase; Adipose Tissue, White; Adiposity; Animals; Diabetes Mellitus, Type 2; Fatty Acid S | 2012 |
Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidaemic mice.
Topics: Animals; Antioxidants; Aortic Valve; Arteriosclerosis; Azo Compounds; Catechin; Cholesterol, HDL; Co | 2003 |
Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects.
Topics: Amino Acids; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Cysteine; Disulfides | 2003 |
Effects of omega-aminosulfonic acids on lipid metabolism in dietary hyperlipidemic rats.
Topics: Adipose Tissue; Animals; Body Weight; Cholesterol; Diet; Hyperlipidemias; Lipid Metabolism; Lipoprot | 1983 |
Protection by taurine against adriamycin-induced proteinuria and hyperlipidemia in rats.
Topics: Acetylglucosaminidase; Animals; Antioxidants; Body Weight; Doxorubicin; Hyperlipidemias; Lipid Perox | 1997 |
Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes.
Topics: Adipose Tissue; Analysis of Variance; Animals; Blood Urea Nitrogen; Body Weight; Cholesterol; Diabet | 2000 |
Hypolipidemic effect of taurine in golden Syrian hamsters.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Cricetinae; Dietary Fats; Dietary Supplements; Disease M | 2000 |
[Effects of taurine and extraction of cristata L on serum Zn, Cu and Ca in rats].
Topics: Animals; Calcium; Cholesterol; Copper; Hyperlipidemias; Male; Plant Extracts; Random Allocation; Rat | 1998 |
Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits.
Topics: Acyl Coenzyme A; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure Determination; Cholester | 2002 |
Effects of taurine on neutrophil function in hyperlipidemic rats.
Topics: Animals; Blood Bactericidal Activity; Cholesterol; Cholesterol, Dietary; Hyperlipidemias; Male; Memb | 1986 |
Some aspects of the metabolism of (35S) methionine in hyperlipemic subjects.
Topics: Chromatography; Chronic Disease; Hepatitis; Humans; Hyperlipidemias; Injections, Intravenous; Methio | 1971 |
The effect of dietary fat on the turnover of cholic acid and on the composition of the biliary bile acids in man.
Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Cocos; Dietary Fats; Female; Glycerides; Glycine; Hu | 1965 |